S.C.L. Langeveld

Gene-modified T cells for adoptive immunotherapy of renal cell cancer maintain transgene-specific immune functions in vivo

C. B. H. W. Lamers, S.C.L. Langeveld, Corrien M. Groot-van Ruijven et al. · Cancer Immunology Immunotherapy · 2007 · 94 citations · Full text

The<i>Helicobacter pylori</i>plasticity region locus<i>jhp0947âjhp0949</i>is associated with duodenal ulcer disease and interleukin-12 production in monocyte cells

Ramon de Jonge, Ernst J. Kuipers, S.C.L. Langeveld et al. · FEMS Immunology & Medical Microbiology · 2004 · 56 citations · Full text

Parallel Detection of Transduced T Lymphocytes After Immunogene Therapy of Renal Cell Cancer by Flow Cytometry and Real-Time Polymerase Chain Reaction: Implications for Loss of Transgene Expression

C. B. H. W. Lamers, J.W. Gratama, Nadine Pouw et al. · Human Gene Therapy · 2005 · 40 citations

Process validation and clinical evaluation of a protocol to generate gene-modified T lymphocytes for imunogene therapy for metastatic renal cell carcinoma: GMP-controlled transduction and expansion of patient's T lymphocytes using a carboxy anhydrase IX-specific scFv transgene

C. B. H. W. Lamers, Pascal van Elzakker, S.C.L. Langeveld et al. · Cytotherapy · 2006 · 35 citations

Cell Therapy, T-regulatory Cell, Immunology +10